Skip to main content

Find Clinical Trials

Home
Conditions
To Determine Bioequivalence Under Fed Conditions

Clinical trial condition

To Determine Bioequivalence Under Fed Conditions

Explore clinical trials studying To Determine Bioequivalence Under Fed Conditions. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

To Determine Bioequivalence Under Fed Conditions trial results

Completed

The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.

NCT05337969

Conditions: To Determine Bioequivalence Under Fed Conditions
Locations: Not specified

View Trial Details

Completed

The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.

NCT05329857

Conditions: To Determine Bioequivalence Under Fed Conditions
Locations: Not specified

View Trial Details

Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

NCT01380496

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Anapharm Inc. Sainte-Foy, Quebec, Canada

View Trial Details

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

NCT00652873

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Anapharm, Inc. Sainte-Foy, Quebec, Canada

View Trial Details

Completed

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

NCT00652821

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Not specified

View Trial Details

Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

NCT00653003

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Not specified

View Trial Details

Completed

Bioavailability Study of Propranolol Under Fed Conditions

NCT00652600

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Not specified

View Trial Details

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

NCT00652704

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Anapharm, Inc. Sainte-Foy, Quebec, Canada

View Trial Details

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

NCT00652730

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Phoenix International Life Sciences inc Saint-Laurent, Quebec, Canada

View Trial Details

Completed

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

NCT01380431

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: PharmaKinetics Laboratories, Inc. Baltimore, Maryland, United States

View Trial Details